ECSP088934A - Formas cristalinas de 11 -(4-acetilfenil)-20,20,21,21,21-pentafluoro-17-hidroxi-19-nor-17 -pregna-4,9-dien-3-ona - Google Patents
Formas cristalinas de 11 -(4-acetilfenil)-20,20,21,21,21-pentafluoro-17-hidroxi-19-nor-17 -pregna-4,9-dien-3-onaInfo
- Publication number
- ECSP088934A ECSP088934A EC2008008934A ECSP088934A ECSP088934A EC SP088934 A ECSP088934 A EC SP088934A EC 2008008934 A EC2008008934 A EC 2008008934A EC SP088934 A ECSP088934 A EC SP088934A EC SP088934 A ECSP088934 A EC SP088934A
- Authority
- EC
- Ecuador
- Prior art keywords
- pregna
- pentafluoro
- dien
- acetilfenil
- hidroxi
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Formas cristalinas de 11?-(4-acetilfenil)-20,20,21,21,21-pentafluoro-17-hidroxi-19-nor-17?-pregna-4,9-dien-3-ona. En particular, dos formas cristalinas de ansolvato/anhidrato de este compuesto, las formas polimórficas I y II. Solvatos cristalinos, por ejemplo, los solvatos de metanol y etanol de 11?-(4-acetilfenil)-20,20,21,21,21-pentafluoro-17-hidroxi-19-nor-17?-pregna-4,9-dien-3-ona, como precursores para la preparación de ambas formas polimórficas I y II. Se describen procesos para la preparación de la forma polimórfica I, por medio de cristalización con desplazamiento o remoción por agitación. La elección del solvente se realiza en función de las diferencias en el comportamiento de purificación de los solvatos individuales de la 11?-(4-acetilfenil)-20,20,21,21,21-pentafluoro-17-hidroxi-19-nor-17?-pregna-4,9-dien-3-ona. La forma polimórfica I de acuerdo con la invención es apropiada para preparar medicamentos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81012706P | 2006-06-02 | 2006-06-02 | |
EP06090095A EP1862468A1 (de) | 2006-06-02 | 2006-06-02 | Kristallines 11beta-(4-Acetylphenyl)-20,20,21,21,21-pentafluor-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-on |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP088934A true ECSP088934A (es) | 2009-01-30 |
Family
ID=37562153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2008008934A ECSP088934A (es) | 2006-06-02 | 2008-12-02 | Formas cristalinas de 11 -(4-acetilfenil)-20,20,21,21,21-pentafluoro-17-hidroxi-19-nor-17 -pregna-4,9-dien-3-ona |
Country Status (15)
Country | Link |
---|---|
US (1) | US7910573B2 (es) |
EP (2) | EP1862468A1 (es) |
JP (1) | JP2009538855A (es) |
KR (1) | KR20090016008A (es) |
AR (1) | AR061151A1 (es) |
AU (1) | AU2007256432A1 (es) |
BR (1) | BRPI0713093A2 (es) |
CA (1) | CA2654126A1 (es) |
EA (1) | EA200802385A1 (es) |
EC (1) | ECSP088934A (es) |
MX (1) | MX2008015348A (es) |
NO (1) | NO20085417L (es) |
TN (1) | TNSN08499A1 (es) |
UY (1) | UY30384A1 (es) |
WO (1) | WO2007140917A2 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006054535A1 (de) * | 2006-11-15 | 2008-05-21 | Bayer Schering Pharma Aktiengesellschaft | Progesteronrezeptorantagonisten |
US8486926B2 (en) * | 2006-11-17 | 2013-07-16 | Harbor Therapeutics, Inc. | Steroid tetrol solid state forms |
DE102009034367A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten |
DE102009034366A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
DE102009034362A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
DE102009034368A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
DE102009034525A1 (de) | 2009-07-21 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
DE102009034526A1 (de) | 2009-07-21 | 2011-02-10 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten |
DE102010007722A1 (de) | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesteronrezeptorantagonisten |
DE102010007719A1 (de) | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesteronrezeptorantagonisten |
US9290293B2 (en) | 2013-01-03 | 2016-03-22 | Samuel A. Tilton | Storage systems and related methods |
US20210171568A1 (en) * | 2017-10-26 | 2021-06-10 | Crystal Pharmaceutical (Suzhou) Co., Ltd. | Crystalline forms of selective progesterone receptor modulator, processes for preparation thereof |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2620707B1 (fr) * | 1987-09-18 | 1989-12-08 | Roussel Uclaf | Nouveaux steroides comportant un cycle spirannique a 3, 4 ou 6 chainons en position 17, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
US4954490A (en) * | 1988-06-23 | 1990-09-04 | Research Triangle Institute | 11 β-substituted progesterone analogs |
FR2644789B1 (fr) * | 1989-03-22 | 1995-02-03 | Roussel Uclaf | Nouveaux steroides 19-nor, 3-ceto comportant une chaine en 17 aminosubstituee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant |
JP3202224B2 (ja) | 1989-08-04 | 2001-08-27 | シエーリング アクチエンゲゼルシヤフト | 11β―アリール―ゴナ―4,9―ジエン―3―オン、その製造方法及びそれを含有する調剤学的調製剤 |
US5407928A (en) * | 1990-08-15 | 1995-04-18 | Schering Aktiengesellschaft | 11β-aryl-gona-4,9-dien-3-ones |
FR2718354B1 (fr) | 1994-04-08 | 1996-05-03 | Roussel Uclaf | Application des composés antiglucocorticoïde pour la préparation de médicaments destinés à la prévention ou au traitement des manifestations liées au syndrome de sevrage des narcotiques et les compositions les renfermant. |
JP4260886B2 (ja) * | 1996-05-01 | 2009-04-30 | アメリカ合衆国 | 新規の抗プロゲステロンとしての21―置換プロゲステロン誘導体 |
FR2757400B1 (fr) | 1996-12-19 | 1999-12-17 | Hoechst Marion Roussel Inc | Application des composes antiglucocorticoides dans le traitement des psychoses ou des comportements addictifs |
DE19706061A1 (de) * | 1997-02-07 | 1998-08-13 | Schering Ag | Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette |
JPH11171774A (ja) | 1997-12-05 | 1999-06-29 | Kyowa Hakko Kogyo Co Ltd | 血球増多剤 |
US6020328A (en) * | 1998-03-06 | 2000-02-01 | Research Triangle Institute | 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
WO1999053924A1 (fr) | 1998-04-17 | 1999-10-28 | Kyowa Hakko Kogyo Co., Ltd. | Agent analgesique |
US6476079B1 (en) * | 1999-12-23 | 2002-11-05 | Leiras Oy | Devices for the delivery of drugs having antiprogestinic properties |
EP1157996A1 (de) * | 2000-05-23 | 2001-11-28 | JENAPHARM GmbH | Neue Festkörperformen des Mesoprogestins 11Beta-[4E-(Hydroxyiminomethyl)-phenyl]-17Alpha-methoxymethyl-17Beta-methoxy-estra-4,9-dien-3-on |
DK1325022T3 (da) * | 2000-09-18 | 2007-02-19 | Applied Research Systems | Fremgangsmåde til fremstilling af 21-hydroxy-6,19-oxidoprogesteron (21OH-6OP) |
DE10051609A1 (de) * | 2000-10-18 | 2002-05-02 | Schering Ag | Hemmung der Wachstumsfaktorabhängigkeit von Tumorzellen |
DE10221034A1 (de) | 2002-05-03 | 2003-11-20 | Schering Ag | 17alpha-Fluoralkyl-11ß-benzaldoxim-Steroide, Verfahren zu deren Herstellung, diese Steroide enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln |
BRPI0513141A (pt) | 2004-07-09 | 2008-04-29 | Population Council Inc | composição para anel vaginal, e, processo de contracepção a longo prazo |
US20070105828A1 (en) * | 2005-08-19 | 2007-05-10 | Glenmark Pharmaceuticals Limited | Novel polymorph form M of mifepristone and process for its preparation |
-
2006
- 2006-06-02 EP EP06090095A patent/EP1862468A1/de not_active Withdrawn
-
2007
- 2007-05-31 JP JP2009512491A patent/JP2009538855A/ja not_active Withdrawn
- 2007-05-31 CA CA002654126A patent/CA2654126A1/en not_active Abandoned
- 2007-05-31 MX MX2008015348A patent/MX2008015348A/es unknown
- 2007-05-31 KR KR1020087032153A patent/KR20090016008A/ko not_active Application Discontinuation
- 2007-05-31 BR BRPI0713093-7A patent/BRPI0713093A2/pt not_active IP Right Cessation
- 2007-05-31 EP EP07725692A patent/EP2024383A2/de not_active Withdrawn
- 2007-05-31 AU AU2007256432A patent/AU2007256432A1/en not_active Abandoned
- 2007-05-31 WO PCT/EP2007/004805 patent/WO2007140917A2/de active Application Filing
- 2007-05-31 EA EA200802385A patent/EA200802385A1/ru unknown
- 2007-06-01 AR ARP070102368A patent/AR061151A1/es unknown
- 2007-06-01 US US11/757,118 patent/US7910573B2/en not_active Expired - Fee Related
- 2007-06-01 UY UY30384A patent/UY30384A1/es not_active Application Discontinuation
-
2008
- 2008-11-28 TN TNP2008000499A patent/TNSN08499A1/en unknown
- 2008-12-02 EC EC2008008934A patent/ECSP088934A/es unknown
- 2008-12-30 NO NO20085417A patent/NO20085417L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20085417L (no) | 2008-12-30 |
EP2024383A2 (de) | 2009-02-18 |
UY30384A1 (es) | 2008-03-31 |
US7910573B2 (en) | 2011-03-22 |
AR061151A1 (es) | 2008-08-06 |
WO2007140917A3 (de) | 2008-04-10 |
CA2654126A1 (en) | 2007-12-13 |
AU2007256432A1 (en) | 2007-12-13 |
BRPI0713093A2 (pt) | 2012-10-16 |
EP1862468A1 (de) | 2007-12-05 |
TNSN08499A1 (en) | 2010-04-14 |
JP2009538855A (ja) | 2009-11-12 |
EA200802385A1 (ru) | 2009-06-30 |
MX2008015348A (es) | 2008-12-17 |
WO2007140917A2 (de) | 2007-12-13 |
US20080085875A1 (en) | 2008-04-10 |
KR20090016008A (ko) | 2009-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP088934A (es) | Formas cristalinas de 11 -(4-acetilfenil)-20,20,21,21,21-pentafluoro-17-hidroxi-19-nor-17 -pregna-4,9-dien-3-ona | |
CO6260076A2 (es) | Derivados de uracilo o timina para el tratamiento de la hepatitis c | |
ECSP088774A (es) | Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmacéuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricación. | |
AR098260A2 (es) | Polimorfo cristalino de una sal de bisulfato de un antagonista del receptor de trombina, proceso para su preparación, composición y forma purificada | |
ECSP099452A (es) | Derivados de éster y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides | |
UY29607A1 (es) | Compuestos quimicos | |
PE20090696A1 (es) | Formas cristalinas de saxagliptina y procesos para preparar las mismas | |
UY31481A1 (es) | Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones | |
UY27427A1 (es) | Nuevas dihidro-pteridinonas, procedimientos para su preparación y su utilización como medicamentos | |
ECSP077271A (es) | Derivados de pirimidina | |
CL2008002132A1 (es) | Compuestos derivados de sulfonamidas, moduladores de trpm8; composiciones farmaceuticas que comprenden a dichos compuestos; y uso de dichos compuestos en el tratamiento del dolor neuropatico, dolor inflamatorio, ansiedad, depresion, hiperalgesia inflamatoria, entre otras. | |
ECSP10010058A (es) | Derivados de quinazolinadiona, su preparación y sus aplicaciones terapéuticas | |
UY30544A1 (es) | Compuestos de pirrolo-piperidina y sales farmacéuticametne aceptables de los mismos, procesos de fabricacion, composiciones y aplicaciones | |
CR10497A (es) | Derivados de piperazinilo utiles en el tratamiento de enfermedades mediadas por el receptor gpr38 | |
AR116001A2 (es) | Composición farmacéutica 271 | |
UY29768A1 (es) | Derivados de benzotiazolonas, procesos para su preparación, composiciones farmacéuticas que los contienen y aplicaciones | |
ECSP066964A (es) | Nuevos beta-agonistas, procedimiento para su preparación y su uso como medicamentos | |
CR9407A (es) | Tetrahidropiridoazepin-8-onas y compuestos relacionados para el tratamiento de la esquizofrenia | |
ECSP067028A (es) | Profármacos de esteroides con acción androgénica | |
CU20080230A7 (es) | Forma cristalinas de 11beta-(4-acetilfenil)-20,20,21,21,21-pentafluoro-17-hidroxi-19-nor-17alfa-pregna-4,9-dien-3-ona | |
DOP2008000063A (es) | Formas cristalinas de 11b-(4-acetilfenil)-20-pentafluoro 17-hidroxi-19-nor-17a-pregna-4,9-dien-3-ona. | |
HN2008001791A (es) | FORMAS CRISTALINAS DE 11B (-4-ACETILFENIL)-20,20,21,21,21-PENTAFLUORO-17-HIDROXI-19-NOR-17a-PREGNA-4,9-DIEN-3-ONA | |
BR0001628A (pt) | Processo para a preparação de um composto aromático substituìdo por uma nitrila terciária | |
DOP2006000065A (es) | Derivado de 5h-benzociclohepteno, procedimiento para su preparacion y su uso como antiinflamatorios. | |
AR052865A1 (es) | Preparacion de compuestos farmaceuticos derivados de sales de piperazina |